Benzinga's Top Downgrades - Esperion Therapeutics (NASDAQ:ESPR)

Piper Jaffray downgraded

National Penn BancsharesNPBC

from Overweight to Neutral. The target price for National Penn Bancshares has been raised from $12 to $13. National Penn Bancshares shares closed at $12.75 yesterday. Analysts at Morgan Stanley downgraded

Re/Max Holdings IncRMAX

to Equal-weight. RE/MAX Holdings shares closed at $37.96 yesterday. Analysts at Citigroup downgraded

Precision Castparts Corp. PCP

from Buy to Neutral. The target price for Precision Castparts has been lowered from $246 to $235. Precision Castparts shares closed at $230.88 yesterday. Piper Jaffray downgraded

Dot Hill Systems Corp. HILL

from Overweight to Neutral. The target price for Dot Hill Systems has been raised from $9 to $9.75. Dot Hill Systems shares closed at $5.18 yesterday. Needham downgraded

Esperion Therapeutics IncESPR

from Strong Buy to Buy. Esperion Therapeutics shares closed at $64.17 yesterday.

Market News and Data brought to you by Benzinga APIs